rs10975882

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015158.5(KANK1):​c.38-11739C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.351 in 152,034 control chromosomes in the GnomAD database, including 10,695 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.35 ( 10695 hom., cov: 32)

Consequence

KANK1
NM_015158.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.163

Publications

1 publications found
Variant links:
Genes affected
KANK1 (HGNC:19309): (KN motif and ankyrin repeat domains 1) The protein encoded by this gene belongs to the Kank family of proteins, which contain multiple ankyrin repeat domains. This family member functions in cytoskeleton formation by regulating actin polymerization. This gene is a candidate tumor suppressor for renal cell carcinoma. Mutations in this gene cause cerebral palsy spastic quadriplegic type 2, a central nervous system development disorder. A t(5;9) translocation results in fusion of the platelet-derived growth factor receptor beta gene (PDGFRB) on chromosome 5 with this gene in a myeloproliferative neoplasm featuring severe thrombocythemia. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 20. [provided by RefSeq, Dec 2014]
KANK1 Gene-Disease associations (from GenCC):
  • spastic quadriplegic cerebral palsy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cerebral palsy, spastic quadriplegic, 2
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.46 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015158.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KANK1
NM_015158.5
MANE Select
c.38-11739C>G
intron
N/ANP_055973.2Q14678-1
KANK1
NM_001256876.3
c.38-11739C>G
intron
N/ANP_001243805.1Q14678-1
KANK1
NM_001256877.3
c.38-11739C>G
intron
N/ANP_001243806.1Q14678-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KANK1
ENST00000382297.7
TSL:1 MANE Select
c.38-11739C>G
intron
N/AENSP00000371734.2Q14678-1
KANK1
ENST00000382303.5
TSL:1
c.38-11739C>G
intron
N/AENSP00000371740.1Q14678-1
KANK1
ENST00000382289.7
TSL:1
c.37+22056C>G
intron
N/AENSP00000371726.3Q5W0W3

Frequencies

GnomAD3 genomes
AF:
0.351
AC:
53380
AN:
151916
Hom.:
10695
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.193
Gnomad AMI
AF:
0.359
Gnomad AMR
AF:
0.269
Gnomad ASJ
AF:
0.488
Gnomad EAS
AF:
0.0954
Gnomad SAS
AF:
0.469
Gnomad FIN
AF:
0.384
Gnomad MID
AF:
0.421
Gnomad NFE
AF:
0.464
Gnomad OTH
AF:
0.375
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.351
AC:
53384
AN:
152034
Hom.:
10695
Cov.:
32
AF XY:
0.348
AC XY:
25865
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.193
AC:
8006
AN:
41486
American (AMR)
AF:
0.268
AC:
4095
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.488
AC:
1694
AN:
3472
East Asian (EAS)
AF:
0.0950
AC:
490
AN:
5156
South Asian (SAS)
AF:
0.469
AC:
2255
AN:
4810
European-Finnish (FIN)
AF:
0.384
AC:
4049
AN:
10558
Middle Eastern (MID)
AF:
0.412
AC:
121
AN:
294
European-Non Finnish (NFE)
AF:
0.464
AC:
31566
AN:
67960
Other (OTH)
AF:
0.371
AC:
783
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1636
3272
4908
6544
8180
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
526
1052
1578
2104
2630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.417
Hom.:
1978
Bravo
AF:
0.331
Asia WGS
AF:
0.223
AC:
781
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
7.4
DANN
Benign
0.71
PhyloP100
-0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10975882; hg19: chr9-699065; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.